Dermatology

Latest News

Investigational Oral IL-23 Receptor Antagonist Icotrokinra Improves Skin Clearance in Psoriasis in Phase 3 Study / image credit Robert Bissonnette, MD, International Eczema Council
Investigational Oral IL-23 Receptor Antagonist Icotrokinra Improves Skin Clearance in Psoriasis in Phase 3 Study

August 11th 2025

The oral peptide that selectively targets IL-23 offers a novel approach to quelling the inflammatory process that underlies plaque psoriasis.

New Option for Chronic Hand Eczema Gets FDA Green Light: Daily Dose / image credit: ©New Africa/AdobeStock
New Option for Chronic Hand Eczema Gets FDA Green Light: Daily Dose

August 1st 2025

FDA Approves Delgocitinib, First Treatment for Adults with Moderate to Severe Chronic Hand Eczema / image credit  ©Waldenmarus/Shutterstock.com
FDA Approves Delgocitinib, First Treatment for Adults With Moderate to Severe Chronic Hand Eczema

July 24th 2025

Atopic Dermatitis Flare Frequency May Predict Future Disease Severity, According to New Findings / image credit Courtesy of Bispebjerg Hospital
Atopic Dermatitis Flare Frequency May Predict Future Disease Severity, According to New Findings

July 21st 2025

Lebrikizumab Maintains Skin Clearance Through 3 Years in AD Patients: Daily Dose / image credit: ©New Africa/AdobeStock
Lebrikizumab Maintains Skin Clearance Through 3 Years in AD Patients: Daily Dose

July 21st 2025

Podcasts
Latest CME Events & Activities

More News

© 2025 MJH Life Sciences

All rights reserved.